• Tue, January 3, 2023

by: WOPRAI

Travis Steed Upgraded (BDX) to Strong Buy and Increased Target to $290 on, Jan 3rd, 2023

by: WOPRAI

Travis Steed Downgraded (BAX) to Hold and Held Target at $55 on, Jan 3rd, 2023

by: WOPRAI

Jorge Araya Upgraded (BAP) to Buy and Held Target at $156 on, Jan 3rd, 2023

by: WOPRAI

Vijay Kumar Downgraded (AZTA) to Hold and Increased Target to $62 on, Jan 3rd, 2023

by: WOPRAI

Matthew Sharpe Maintained (BAH) at Buy with Increased Target to $118 on, Jan 3rd, 2023

by: WOPRAI

Jason Goldberg Maintained (BAC) at Buy with Decreased Target to $48 on, Jan 3rd, 2023

by: WOPRAI

Swayampakula Ramakanth Maintained (VCEL) at Strong Buy with Increased Target to $37 on, Jan 3rd, 2023

by: WOPRAI

Jason Goldberg Upgraded (USB) to Buy and Increased Target to $68 on, Jan 3rd, 2023

by: WOPRAI

Jason Goldberg Maintained (WFC) at Buy with Increased Target to $64 on, Jan 3rd, 2023

by: WOPRAI

Jeanine Wai Maintained (XOM) at Buy with Increased Target to $129 on, Jan 3rd, 2023

by: WOPRAI

Daniel Politzer Upgraded (WYNN) to Buy and Increased Target to $101 on, Jan 3rd, 2023

by: WOPRAI

Jerome Ramel Downgraded (AAPL) to Hold and Held Target at $140 on, Jan 3rd, 2023

by: WOPRAI

Yatin Suneja Upgraded (ACAD) to Strong Buy and Held Target at $22 on, Jan 3rd, 2023

by: WOPRAI

Mohit Bansal Maintained (BMY) at Hold with Increased Target to $78 on, Jan 3rd, 2023

by: WOPRAI

Jason Goldberg Maintained (BK) at Buy with Increased Target to $64 on, Jan 3rd, 2023

by: WOPRAI

Raghuram Selvaraju Maintained (ADMA) at Strong Buy with Increased Target to $4.5 on, Jan 3rd, 2023

by: WOPRAI

Vincent Anderson Maintained (ADM) at Strong Buy with Increased Target to $116 on, Jan 3rd, 2023

by: WOPRAI

Michael Schmidt Upgraded (ADAP) to Strong Buy and Held Target at $5 on, Jan 3rd, 2023

by: WOPRAI

Vijay Kumar Downgraded (ZBH) to Hold and Held Target at $130 on, Jan 3rd, 2023

by: WOPRAI

Jason Goldberg Downgraded (ZION) to Sell and Decreased Target to $59 on, Jan 3rd, 2023

by: WOPRAI

Derek Archila Maintained (ASND) at Buy with Increased Target to $177 on, Jan 3rd, 2023

by: WOPRAI

Raghuram Selvaraju Maintained (AVXL) at Strong Buy with Increased Target to $50 on, Jan 3rd, 2023

by: WOPRAI

Jason Goldberg Maintained (C) at Hold with Increased Target to $61 on, Jan 3rd, 2023

by: WOPRAI

Matthew Sharpe Upgraded (CACI) to Buy and Increased Target to $355 on, Jan 3rd, 2023

by: WOPRAI

Derek Archila Maintained (CABA) at Buy with Increased Target to $14 on, Jan 3rd, 2023

by: WOPRAI

Derek Archila Downgraded (ARVN) to Hold and Decreased Target to $49 on, Jan 3rd, 2023

by: WOPRAI

Derek Archila Downgraded (APLS) to Hold and Held Target at $58 on, Jan 3rd, 2023

by: WOPRAI

Michael Brown Downgraded (APO) to Hold and Held Target at $77 on, Jan 3rd, 2023

by: WOPRAI

Derek Archila Maintained (CCCC) at Hold with Decreased Target to $9 on, Jan 3rd, 2023

by: WOPRAI

Derek Archila Upgraded (BPMC) to Hold and Held Target at $41 on, Jan 3rd, 2023

by: WOPRAI

Matthew Boss Downgraded (BRLT) to Hold and Decreased Target to $6 on, Jan 3rd, 2023

by: WOPRAI

Raghuram Selvaraju Maintained (BTAI) at Strong Buy with Decreased Target to $73 on, Jan 3rd, 2023

by: WOPRAI

Mark Massaro Initiated (SOPH) at Strong Buy and Held Target at $6 on, Jan 3rd, 2023

by: WOPRAI

Anupam Rama Initiated (SNDX) at Buy and Held Target at $41 on, Jan 3rd, 2023

by: WOPRAI

Jason Goldberg Maintained (STT) at Buy with Increased Target to $116 on, Jan 3rd, 2023

by: WOPRAI

Chris Carey Maintained (STZ) at Buy with Decreased Target to $270 on, Jan 3rd, 2023

by: WOPRAI

David Koning Upgraded (SQ) to Buy and Increased Target to $78 on, Jan 3rd, 2023

by: WOPRAI

Jeffrey Sprague Upgraded (ALLE) to Strong Buy and Held Target at $128 on, Jan 3rd, 2023

by: WOPRAI

Jason Goldberg Downgraded (ALLY) to Hold and Decreased Target to $33 on, Jan 3rd, 2023

by: WOPRAI

Donald Fandetti Maintained (ALLY) at Sell with Decreased Target to $20 on, Jan 3rd, 2023

by: WOPRAI

Linda Tsai Downgraded (AMH) to Hold and Decreased Target to $32 on, Jan 3rd, 2023

by: WOPRAI

Mohit Bansal Maintained (AMGN) at Hold with Increased Target to $285 on, Jan 3rd, 2023

by: WOPRAI

Chris Carey Downgraded (TAP) to Sell and Held Target at $45 on, Jan 3rd, 2023

by: WOPRAI

Stephen Baxter Upgraded (UHS) to Hold and Held Target at $154 on, Jan 3rd, 2023

  • Fri, December 30, 2022

by: WOPRAI

Mayank Mamtani Maintained (TGTX) at Strong Buy with Increased Target to $23 on, Dec 30th, 2022

by: WOPRAI

Corinne Jenkins Maintained (TGTX) at Strong Sell with Increased Target to $6 on, Dec 30th, 2022

by: WOPRAI

Joshua Schimmer Maintained (TGTX) at Buy with Increased Target to $16 on, Dec 30th, 2022

by: WOPRAI

Yigal Nochomovitz Maintained (ARDX) at Strong Buy with Increased Target to $7 on, Dec 30th, 2022

Corinne Jenkins Maintained (TGTX) at Strong Sell with Increased Target to $6 on, Dec 30th, 2022

Corinne Jenkins of Goldman Sachs, Maintained "TG Therapeutics, Inc." (TGTX) at Strong Sell with Increased Target from $4 to $6 on, Dec 30th, 2022.

Corinne has made no other calls on TGTX in the last 4 months.



There are 2 other peers that have a rating on TGTX. Out of the 2 peers that are also analyzing TGTX, 0 agree with Corinne's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Corinne

  • Alec Stranahan of "B of A Securities" Maintained at Sell with Increased Target to $6 on, Thursday, December 29th, 2022
  • Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Thursday, December 29th, 2022

Like: 👍